|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/48 | |
| A61P 31/18 |
| (11) | Number of the document | 2131865 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08742083.2 |
| Date of filing the European patent application | 2008-03-12 | |
| (97) | Date of publication of the European application | 2009-12-16 |
| (45) | Date of publication and mention of the grant of the patent | 2014-12-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/003354 |
| Date | 2008-03-12 |
| (87) | Number | WO 2008/112289 |
| Date | 2008-09-18 |
| (30) | Number | Date | Country code |
| 906330 P | 2007-03-12 | US |
| (72) |
RIGGS-SAUTHIER, Jennifer, US
CHENG, Lin, US
VIEGAS, Tacey, X., US
GU, Xuyuan, US
DUARTE, Franco, J., US
ZHANG, Wen, US
|
| (73) |
Nektar Therapeutics,
455 Mission Bay Boulevard South, Suite 100, San Francisco, CA 94158,
US
|
| (54) | OLIGOMER-PROTEASE INHIBITOR CONJUGATES |
| OLIGOMER-PROTEASE INHIBITOR CONJUGATES |